AETHLON MEDICAL, INC. Deferred Revenue, Revenue Recognized
AETHLON MEDICAL, INC. (AEMD) reported Deferred Revenue, Revenue Recognized of $318.58 thousand for the 3-month period ending 2020-12-31, per its 10-Q filed 2022-02-14.
Discontinued › Income Statement › Other Income
us-gaap:DeferredRevenueRevenueRecognized1 · last filed 2022-02-14
- AETHLON MEDICAL, INC. deferred revenue, revenue recognized for the quarter ending 2020-12-31 was $318.58K.
| Period end | Deferred Revenue, Revenue Recognized 3 month |
|---|---|
| 2020-12-31 | $318.58K 10-Q · filed 2022-02-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B | |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |
| enVVeno Medical Corp (NVNO) | United States | $0.006B | -0.48 |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |
| Co-Diagnostics, Inc. (CODX) | United States | $0.007B | -0.32 |